Nkarta
Utility Patent Applications

Last updated:

List of all Nkarta patents 8 in total

Status Patent
Application
Utility: CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN IMMUNOTHERAPY External link
Filling date: 7 Sep 2025 Issue date: 28 Jul 2022
Application
Utility: METHODS FOR THE SIMULTANEOUS EXPANSION OF MULTIPLE IMMUNE CELL TYPES, RELATED COMPOSITIONS AND USES OF SAME IN CANCER IMMUNOTHERAPY External link
Filling date: 7 Sep 2025 Issue date: 17 Feb 2022
Application
Utility: GENETICALLY MODIFIED NATURAL KILLER CELLS FOR CD70-DIRECTED CANCER IMMUNOTHERAPY External link
Filling date: 7 Sep 2025 Issue date: 6 Jan 2022
Application
Utility: NATURAL KILLER CELL COMPOSITIONS AND IMMUNOTHERAPY METHODS FOR TREATING TUMORS External link
Filling date: 7 Sep 2025 Issue date: 4 Nov 2021
Application
Utility: IMMUNE CELLS ENGINEERED TO EXPRESS CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN IMMUNOTHERAPY External link
Filling date: 7 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF IN IMMUNOTHERAPY External link
Filling date: 7 Sep 2025 Issue date: 11 Mar 2021
Application
Utility: CANCER IMMUNOTHERAPY USING CD19-DIRECTED CHIMERIC ANTIGEN RECEPTORS External link
Filling date: 7 Sep 2025 Issue date: 4 Mar 2021
Application
Utility: Truncated NKG2D Chimeric Receptors And Uses Thereof In Natural Killer Cell Immunotherapy External link
Filling date: 7 Sep 2025 Issue date: 30 Apr 2020

Showing 1 to 8 of 8 patents.